Page last updated: 2024-11-03

ag 1879 and Hormone-Dependent Neoplasms

ag 1879 has been researched along with Hormone-Dependent Neoplasms in 2 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Research Excerpts

ExcerptRelevanceReference
"These data suggest that GCP, an isoflavone-enriched compound with minimal side-effects and far superior intestinal absorption rate of genistein, has significant clinical potential in combination with docetaxel, bicalutamide or targeted agents for the treatment of advanced CaP."1.35Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines. ( Burich, RA; Holland, WS; Mack, PC; Tepper, C; Vinall, RL; White, RW, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burich, RA1
Holland, WS1
Vinall, RL1
Tepper, C1
White, RW1
Mack, PC1
Fan, P1
McDaniel, RE1
Kim, HR1
Clagett, D1
Haddad, B1
Jordan, VC1

Other Studies

2 other studies available for ag 1879 and Hormone-Dependent Neoplasms

ArticleYear
Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
    BJU international, 2008, Volume: 102, Issue:10

    Topics: Androgens; Anilides; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Docetaxel; Dr

2008
Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
    European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:18

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Divis

2012